Get the Stockscreener App
0.00
100.00%
-0.6063
23 Andme Holding Co stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
See More
Previous Close:
$0.6063
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$82.91M
Revenue:
$247.99M
Net Income/Loss:
$-521.97M
P/E Ratio:
0.00
EPS:
-1.11
Net Cash Flow:
$-194.28M
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.00
$0.00
52-Week Range:
$0.00
$10.81
23 Andme Holding Co Stock (ME) Company Profile
Name
23 Andme Holding Co
Sector
Industry
Phone
(650) 938-6300
Address
223 N. MATHILDA AVE., SUNNYVALE
Compare ME with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ME
23 Andme Holding Co
|
0.00 | 82.91M | 247.99M | -521.97M | -194.28M | -1.11 |
|
TMO
Thermo Fisher Scientific Inc
|
414.11 | 152.38B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
204.80 | 138.18B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
523.42 | 42.21B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
119.64 | 32.65B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
158.76 | 25.59B | 15.50B | 1.33B | 2.16B | 7.34 |
23 Andme Holding Co Stock (ME) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-29-22 | Initiated | Berenberg | Buy |
| Sep-22-22 | Initiated | Cowen | Outperform |
| Nov-15-21 | Downgrade | Citigroup | Buy → Neutral |
| Aug-17-21 | Initiated | Credit Suisse | Outperform |
| Jul-12-21 | Initiated | Citigroup | Buy |
23 Andme Holding Co Stock (ME) Latest News
Senate holds hearing on 23andMe, concerns over company selling customers’ data (Video) - Social News XYZ
Congress Grills 23andMe on Data Privacy as States Take Legal Action Over Company Sale - The HIPAA Journal
IP, Health Law Scholars Object To 23andMe Ch. 11 Data Sale - Law360
23andme genetic privacy concerns garner Congressional scrutiny - BioWorld MedTech
23andMe Holding Co. SEC 10-K Report - TradingView
Senator Calls For 23AndMe Customers To Sue Company 'Into Oblivion' - Newsweek
Senate holds hearing on 23andMe, concerns over company selling customers' data - CBS News
States Sue To Block 23andMe From Selling DNA Data In Ch. 11 - Law360
23andMe (MEHCQ) Faces Legal Challenge Over Genetic Data Sale - GuruFocus
23andMe Privacy Reviewer’s Law Firm Discloses Work for Regeneron - Bloomberg Law News
US states sue 23andMe to protect customers' private data - marketscreener.com
23andMe sued by state attorneys general over plans to sell genetic data - Seeking Alpha
New York AG sues 23andMe to protect customers' private data - marketscreener.com
23andMe’s Proposed Banruptcy Sale Prompts Challenge From States - Bloomberg Law News
23andMe seeks second auction as ex-CEO outbids Regeneron - MSN
23andMe Reopens Bidding, Jackson Walker Mediates Fee Suit - Law360
Millennium Management LLC Has $720,000 Holdings in 23andMe Holding Co. (NASDAQ:ME) - Defense World
The New Twist In Regeneron's 23andMe Bankruptcy Buyout - Investor's Business Daily
Bankruptcy Was Good for 23andMe - Bloomberg.com
23andMe Sets New Auction With $305 Million New Bid From Ex-CEO - Bloomberg.com
23andMe’s DNA Data Soars in Value With New $305 Million Bid - MSN
23andMe (MEHCQ) Faces Second Auction as Former CEO Bids $305M - GuruFocus
23andMe’s DNA data gets boosted $305m bid in new auction - Moneyweb
Genetic testing company 23andMe to re-auction over 15 million customers' DNA data with bid starting at $305mn — Details - Mint
23andMe, Bidders Agree To Post-Ch. 11 Auction Offer Process - Law360
23andMe seeks new bids after $305 million offer from its co-founder - Reuters
23 and You: The Privacy and National Security Implications of the 23andMe Bankruptcy - Senate Committee on the Judiciary (.gov)
23andMe Judge Questions Limits for New Auction for Bankrupt Firm - Bloomberg
Northern Trust Corp Sells 562,535 Shares of 23andMe Holding Co. (NASDAQ:ME) - Defense World
Canada Customers Agree To Halt 23andMe Data Breach Suits - Law360
23andMe Bankruptcy Judge Ponders Trump Bill’s Injunction Impact - Bloomberg Law News
23andMe Founder Pushes Alternative Ch. 11 Sale - Law360
23andMe founder aims to restart auction with major corporate backing - Reuters
Regeneron to buy bankrupt 23andMe, vows ethical use of customer DNA data (May 19) - marketscreener.com
Here’s how to file a claim amid 23andMe bankruptcy - FOX4KC.com
Anne Wojcicki plans to object to 23andMe's bankruptcy court sale - The Business Journals
23andMe to delist from Nasdaq and deregister with SEC By Investing.com - Investing.com South Africa
23andMe Announces Intent to Voluntarily Delist from Nasdaq and Deregister with the SEC - GlobeNewswire
23andMe Agrees To Sale, Rite Aid Pharmacy Deals Get OK - Law360
23Andme Announces Intent To Voluntarily Delist From Nasdaq & Deregister With SEC - marketscreener.com
23andMe to delist from Nasdaq and deregister with SEC - Investing.com Australia
23andMe Takes Final Step to Exit Nasdaq: Voluntary Delisting After March Bankruptcy Filing - Stock Titan
Jane Street Group LLC Has $836,000 Stock Position in 23andMe Holding Co. (NASDAQ:ME) - Defense World
Senators Unveil DNA Privacy Bill Amid 23andMe's Ch. 11 Sale - Law360
23andMe Holding Co. (OTC:MEHCQ) Was Worth A Lot More Than People Thought, Says Jim Cramer - MSN
Regeneron Enters into Agreement to Acquire Consumer Genetics Business - thehudsonindependent.com
REGN Signs $256M Buyout Deal With 23andMe to Boost Genomics Research - MSN
Genetic Data From 23andMe Ends Up With This Company In $256 Million Deal - AOL.com
23 Andme Holding Co Stock (ME) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):